Skip to content
Posted on March 31, 2023 by: eqs

开拓药业公布2022年度业绩:持续深耕差异化创新,皮科管线表现亮眼

Voice of Asia | Singapore

Singapore News & Headlines, Press Releases & Events

Posted on March 31, 2023 by: eqs

开拓药业公布2022年度业绩:持续深耕差异化创新,皮科管线表现亮眼

  • Home
  • SEAPRWire
  • EQS Newswire
  • ACN Newswire
  • JCN Newswire
  • Contact

Tag: drug

  • Home
  • drug
Posted on January 12, 2023 by: acn

Novotech Acquires US-based Drug Development Consulting Firm, CBR International

       

SINGAPORE, Jan 12, 2023 – (ACN Newswire via SEAPRWire.com) – Novotech, the leading Asia Pacific-centered biotech CRO today announced the acquisition of CBR International, a …

Continue Reading
Posted on December 15, 2022 by: acn

Preventing Strokes and Heart Attacks Doesn't Have to Come with the Risk of Life-threatening Bleeding

       

FREMONT, CA, Dec 14, 2022 – (ACN Newswire via SEAPRWire.com) – Verseon is delighted to announce that the European Journal of Medicinal Chemistry has published …

Continue Reading
Posted on December 6, 2022 by: acn

Novotech Awarded the Asia Pacific CRO of the Year 2022 for Best Practices in Clinical Trials

       

SYDNEY, AU, Dec 6, 2022 – (ACN Newswire via SEAPRWire.com) – Novotech, the leading Asia Pacific biotech specialist CRO, has been awarded the Frost & …

Continue Reading
Posted on November 15, 2022 by: eqs

巨生医MPB-1734抗癌药物新剂型取得成分专利

       

EQS 新闻 via SEAPRWire.com / 2022-11-15 / 10:41 UTC+8 【巨生生医(6827)巨生医MPB-1734取得成分专利新闻稿】 发布日期:2022年11月15日 巨生医MPB-1734抗癌药物新剂型…

Continue Reading
Posted on November 2, 2022 by: jcn

Eisai Announces Plans to Submit Application for Partial Change to Label for Dosage and Administration of Aricept for Treatment of Dementia with Lewy Bodies Based on Results of Drug Reexamination

       

TOKYO, Nov 2, 2022 – (JCN Newswire via SEAPRWire.com) – Eisai Co., Ltd. announced today that it has received notification that Aricept (donepezil hydrochloride), a …

Continue Reading
Posted on October 10, 2022 by: acn

Hua Medicine’s Innovative First-In-Class Glucokinase Activator (GKA) HuaTangNing Is Approved, New Type 2 Diabetes Treatment Paradigm to Begin in China

       

SHANGHAI, CHINA, Oct 10, 2022 – (ACN Newswire via SEAPRWire.com) – Hua Medicine (the “Company”, HKEx Stock Code: 2552.HK) today announces that the New Drug …

Continue Reading
Posted on July 26, 2022 by: acn

Apollomics Inc. Expands Leadership Team with Appointment of Jane Wang, PhD as Chief Scientific Officer

       

Foster City, CA, and Hangzhou, China, Jul 26, 2022 – (ACN Newswire via SEAPRWire.com) – Apollomics Inc. an innovative biopharmaceutical company committed to the discovery …

Continue Reading

Categories

  • ACN Newswire
  • EQS Newswire
  • JCN Newswire
  • SEAPRWire

Recent Stories

  • 开拓药业公布2022年度业绩:持续深耕差异化创新,皮科管线表现亮眼
  • 现代牙科集团公布2022年全年业绩 纯利2.2亿港元录得历史以来第二高位 构建高质量发展的综合牙科生态圈
  • Ocumension Therapeutics Announces 2022 Annual Results
  • VC Holdings Announces 2022 Annual Results
  • 嘉泓物流 (2130.HK) 公布2022全年业绩 收益按年增长4.3%至约27.9亿港元
  • 欧康维视公布2022年全年业绩
  • 汇盈控股公布2022全年业绩
  • 中国中车2022年经营业绩稳中向好
  • Honda: Notice of Change in Capital Structure of Hitachi Astemo including Capital Participation of JIC Capital
  • ESPRIT Announces Annual Results for FY 2022
  • Alltronics 2022 Profit Surges 61.6%, Driven by Robust Cost Control and Better Product Mix
  • Apollomics, a Company Developing Novel Oncology Therapies to Address Difficult-to-Treat Cancers, Announces Closing of Business Combination and Listing on Nasdaq
  • Baguio Green’s 2022 Net Profit* Increased by 3.2 times, Contracts On Hand Recorded a Historical High with a Surge of 67% to HK$3.6 billion
  • 华讯有效控制成本及提升产品组合 2022年溢利上升61.6%
  • 冠科美博(Apollomics Inc.)宣布完成和SPAC Maxpro合并,并在纳斯达克上市

Menu

  • Home
  • About Us
  • Contact Us
  • Term of Use
  • RSS Feed

Links

  • YAHOO
  • NASDAQ
  • Bloomberg
  • Newswire
  • EastMud
  • AsiaEase
  • NetDace
  • HKBrowse
  • AccessTH
  • AseanTrend
Copyright © 2023 VOASA